Interestingly, the dysferlin-like reactivity was detected in myofibers of boldine-treated bIAJ mice, suggesting Cx HCs as part of a novel pathophysiologic mechanism that explains many features of dysferlinopathies. This evidence concerns the gene DYSF and neuromuscular disease caused by qualitative or quantitative defects of dysferlin.